Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability

<p>ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer types in petri dishes and animal models by targeting a [&hellip;]</p>